ABSTRACT

Clinicians are well aware that different therapeutic approaches have to be used to counteract inflammation, pain, tissue destruction or to assist the repair process.

Although IL-1 and TNF share biological activities in most of the above, there are quantitative differences between them. For instance, in the context of inflammation TNF has a strong biological effect on endothelial cells, more so than IL-1, by inducing endothelial leukocyte adhesion molecule (ELAM), which facilitates the adherence of blood leukocytes to the endothelial surface.